Harnessing Real-World Data for Market Access Success

Join WEP’s Market Access Team for a webinar focused on the transformative impact of real-world data (RWD) in rare diseases, oncology, and advanced therapies.

Dive deep into live examples of how RWD has supported market access outcomes and helped companies prepare for successful product launch.

We will provide insight into the strategic decisions behind running a RWD study; share best practices for conducting one effectively; and give updates on the latest regulatory requirements. 

Complete the form to the right to register for this free event.

Meet the Speakers

Picture of Heather Masters

Heather Masters

Vice President, Global Market Access

Picture of Linda McNamara

Linda McNamara

Senior Director, Market Access


What We Will Cover

Discuss strategies for designing and executing RWD studies.

Evaluate decision criteria for selecting RWD studies versus trials or registries.

Understand how RWD can fill various data gaps, including patient-reported outcomes and health economic evaluations, and learn how to convert RWD into robust Real-World Evidence.

Understand the latest regulatory requirements on how RWD can be leveraged to inform HTA decisions.

Seamlessly integrate RWD collection into Early Access initiatives to support regulatory and market access strategies.

See examples of RWD driving successful regulatory and market access objectives.

Webinar Strats in